First Time Loading...

Cofoe Medical Technology Co Ltd
SZSE:301087

Watchlist Manager
Cofoe Medical Technology Co Ltd Logo
Cofoe Medical Technology Co Ltd
SZSE:301087
Watchlist
Price: 37.69 CNY -0.69% Market Closed
Updated: May 8, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Cofoe Medical Technology Co Ltd

Wall Street analysts forecast Cofoe Medical Technology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Cofoe Medical Technology Co Ltd is 49 CNY .

Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
49 CNY
30% Upside
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
49 CNY
30% Upside
Highest
Price Target
Not Available
Cofoe Medical Technology Co Ltd Competitors:
Price Targets
B
2216
Broncus Holding Corp
88% Upside
IRIX
IRIDEX Corp
27% Downside
MDT
Medtronic PLC
18% Upside
CREO
Creo Medical Group PLC
162% Upside
B
2216
Broncus Holding Corp
88% Upside
IRIX
IRIDEX Corp
27% Downside
MDT
Medtronic PLC
18% Upside
CREO
Creo Medical Group PLC
162% Upside
EKF
EKF Diagnostics Holdings PLC
17% Upside
J
300529
Jafron Biomedical Co Ltd
10% Upside
AMPLI
Amplitude Surgical SA
49% Upside
IPD
ImpediMed Ltd
123% Upside

Revenue
Forecast

Revenue Estimate
Cofoe Medical Technology Co Ltd

For the last 3 years the compound annual growth rate for Cofoe Medical Technology Co Ltd's revenue is 27%. The projected CAGR for the next 3 years is 20%.

27%
Past Growth
20%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Cofoe Medical Technology Co Ltd

For the last 3 years the compound annual growth rate for Cofoe Medical Technology Co Ltd's operating income is 22%. The projected CAGR for the next 3 years is 35%.

22%
Past Growth
35%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Cofoe Medical Technology Co Ltd

For the last 3 years the compound annual growth rate for Cofoe Medical Technology Co Ltd's net income is 35%. The projected CAGR for the next 3 years is 30%.

35%
Past Growth
30%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Cofoe Medical Technology Co Ltd's stock price target?
Price Target
49 CNY

According to Wall Street analysts, the average 1-year price target for Cofoe Medical Technology Co Ltd is 49 CNY .

What is Cofoe Medical Technology Co Ltd's Revenue forecast?
Projected CAGR
20%

For the last 3 years the compound annual growth rate for Cofoe Medical Technology Co Ltd's revenue is 27%. The projected CAGR for the next 3 years is 20%.

What is Cofoe Medical Technology Co Ltd's Operating Income forecast?
Projected CAGR
35%

For the last 3 years the compound annual growth rate for Cofoe Medical Technology Co Ltd's operating income is 22%. The projected CAGR for the next 3 years is 35%.

What is Cofoe Medical Technology Co Ltd's Net Income forecast?
Projected CAGR
30%

For the last 3 years the compound annual growth rate for Cofoe Medical Technology Co Ltd's net income is 35%. The projected CAGR for the next 3 years is 30%.

ALPHA SPREAD
Join more than 135,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.